Yash Life Sciences is an indelible hallmark corporation bound by its solemn duty of manufacturing quality and affordable medicines. The entrepreneurial acumen to business with singular cause of “we care” will propel Yash Life Sciences to greater magnitude in the field of pharmaceutical innovation through research and development. Yash Life Sciences aims to reach over the horizon. With trusted vision, strategic insights and increased proficiency, the services would expand to other parts of the world. Yash Life Sciences is a commitment to mitigate the suffering of the disadvantaged. We shall manufacture and deliver essential medicines of the highest quality to the community.
Since its inception in August 2019, Yash Life Sciences has made significant footprint in the local market with household brands like Triphen, Trilyn, Trisept and a wide range of essential generic medicines. We are proving to be one of the major quality employment generators in the industry and the saga would continue with growth and demand. Our focus is central to the science of innovation and research. We are eager to collaborate across scientific and geographical boundaries so that newer and breakthrough technologies are adopted to augment treatment goals. Our team of scientists are dedicated to drug development projects to impact lives positively. Leveraging on the basic principle of innovative science and technology to address the pressing healthcare needs of the society, Yash Life Sciences remain resolute to improve quality of life of millions living on the fringe of the society.
Yash Life Sciences is committed to uncompromised standards of patient safety and compliance. Our quality management protocols are practiced thoroughly and in letter and spirit.Yash Life Sciences would uphold the highest standards of Integrity, honesty and truthfulness in everything it does. To drive innovation, performance and reputation, we have a highly inspired and curious team of people. The very imaginative and unbossed people are encouraged to bring a paradigm shift aimed at improving the lives of people. Our team works at operational excellence to deliver a highly integrated value chain. Yash Life Sciences serves Quality Medicines with LOVE CARE and COMPASSION.
"...ensure that Zambia and the region no longer struggle for essential medicines"
Lack of access to medicines causes a cascade of misery and suffering… In consonant with WHO guidelines and driven by the pioneering spirit, empathy and dynamism, Yash Life Sciences is committed to bridge the gap in improving access to safe, effective and quality-assured essential medicines.
"...based in Shimabala, Kafue town on the outskirts of the capital city of Zambia, Lusaka. "
The home or hub to innovation, Yash Life Sciences is nestled in Shimabala, Kafue on the outskirt of Lusaka, Zambia overlooking the gorgeous surrounding of the mighty Kafue River valley. The setting is pristine, quiet and majestic…worth a visit for the discerning!
"...accredited with GMP certification by the Zambian regulatory authority"
Yash Life Sciences believes in doing the right things for the greater and common good. Attaining various accreditations with time and sound beginning with cGMP – ZAMRA is a testimony to our unwavering commitment to quality.
An estimated 2 billion people still do not have access to essential medicines. This leaves enough room for falsified products to flourish in the susceptible markets due to lack of a coordinated supply chain network.
Yash Life Sciences with rich experience in distribution network has been proactively advocating the fundamental issue of access to medicine through a robust supply chain network. Our strategic geographical location in Zambia can promptly supply essential medicines to the entire neighborhood in the shortest possible time compared to imports from anywhere else in the world.
Yash Life Sciences shall work to the specific need of its customers through detailed planning at all levels of manufacturing and supply chain. This is to make sure that the supply of crucial essential medicines is guaranteed and sustained. We shall continuously look for ways to strengthen our supply chain network index by concentrating on operational excellence and network efficiency.
There is more to do for people living in low- and middle-income countries for improving access to safe, effective and efficacious medicines….
Unit-1: Non Penicillin Facility Commissioned on 20th August 2019, this massive brand new state-of–the-art facility has the built-incapacity to manufacture;
• Liquids
• Tablets
• Capsules
Unit-2:The plant is dedicated to produce Penicillin derivatives – Under construction;
• Dry powder
• Tablets
• Capsules